LAG3 and leukemia: Increasing the expression of LAG-3 and LAG-3+ immune cells in patients with solid tumors or leukemia has been associated with tumor progression, poor prognosis, and unfavorable clinical outcomes, strongly indicating that LAG-3 contributes to immune escape by tumor cells.